John Libbey Eurotext

European Journal of Dermatology

Efficacy of intravenous immunoglobulins for the treatment of mucous membrane pemphigoid-like epidermolysis bullosa acquisita Volume 27, issue 5, September-October 2017

Figures

  • Figure 1
Authors
1 Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan
2 Kurume University Institute of Cutaneous Cell Biology, Kurume, Fukuoka, Japan
3 Singapore Immunology Network (SIgN) and Institute of Medical Biology, Agency for Science, Technology and Research (A*STAR), Biopolis, Singapore

Mucous membrane pemphigoid (MMP)-like epidermolysis bullosa acquisita (EBA) is a severe and intractable phenotypic variant of EBA [1, 2]. We report a case of oral-predominant MMP-like EBA (oral EBA) successfully treated with intravenous immunoglobulins (IVIg).A man in his seventies developed oral pain and blistering. The aphthae and blisters were localized in the oral cavity, lips, tongue, and flexor sides of the wrists (figure 1A-C). No other mucous lesions were observed. Fibroscopic examination [...]